- Profil
- Soziale Medien
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Top-tier venture capital practice that is our preferred choice for any UK deal. The team has great knowledge of the latest trends and market practices, while being pragmatic and not shy to recommend a way forward, which ensures a high degree of deal certainty.’
‘Ross McNaughton and Oli Denne. They both have solid commercial acumen and an ability to distil the negotiation dynamics into clear recommendations of how to quickly find a way forward. While having our best interest in mind, they are great at project managing transactions, keeping stakeholders informed and aligned - also when representing a syndicate of multiple investors.’
‘Extremely deep knowledge about the international biotech space. Experts in both licensing, fund raising and M&A. Pragmatic, realistic, and bridge builders. Particularly strong with academic and university led spin outs and managing expectations and inexperience that lead to a fair consensus.’
Kernmandanten
- Apollo Therapeutics
- Nuclera
- CamenaBio
- Tagomics
- Infinitopes
- Alveogene
- 2150
- Lingotto
- Multiomic Health
- CodingBio
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Ross McNaughton
Weitere Kernanwält*innen
Adrian Toutoungi; Oli Denne